Moore Capital Management LP Acquires Shares of 178,461 Teladoc Health, Inc. (NYSE:TDOC)

Moore Capital Management LP acquired a new position in shares of Teladoc Health, Inc. (NYSE:TDOC - Free Report) in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor acquired 178,461 shares of the health services provider's stock, valued at approximately $1,622,000. Moore Capital Management LP owned 0.10% of Teladoc Health at the end of the most recent quarter.

Other large investors have also modified their holdings of the company. Robeco Institutional Asset Management B.V. boosted its holdings in Teladoc Health by 21.8% in the 4th quarter. Robeco Institutional Asset Management B.V. now owns 700,166 shares of the health services provider's stock valued at $6,365,000 after purchasing an additional 125,111 shares during the period. Nisa Investment Advisors LLC increased its position in shares of Teladoc Health by 20,936.8% during the 4th quarter. Nisa Investment Advisors LLC now owns 426,206 shares of the health services provider's stock worth $3,874,000 after purchasing an additional 424,180 shares in the last quarter. Charles Schwab Investment Management Inc. increased its position in shares of Teladoc Health by 18.7% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 2,443,713 shares of the health services provider's stock worth $22,213,000 after purchasing an additional 384,528 shares in the last quarter. Geode Capital Management LLC increased its position in shares of Teladoc Health by 0.6% during the 4th quarter. Geode Capital Management LLC now owns 3,947,831 shares of the health services provider's stock worth $35,894,000 after purchasing an additional 22,664 shares in the last quarter. Finally, Commonwealth Equity Services LLC increased its position in Teladoc Health by 35.7% in the 4th quarter. Commonwealth Equity Services LLC now owns 113,563 shares of the health services provider's stock valued at $1,032,000 after acquiring an additional 29,903 shares in the last quarter. 76.82% of the stock is owned by institutional investors.

Analyst Ratings Changes

Several equities research analysts have weighed in on TDOC shares. Needham & Company LLC restated a "hold" rating on shares of Teladoc Health in a research report on Thursday, May 1st. Canaccord Genuity Group lowered their price objective on shares of Teladoc Health from $14.00 to $12.00 and set a "buy" rating for the company in a research report on Thursday, May 1st. Bank of America lowered their price objective on shares of Teladoc Health from $9.50 to $8.00 and set a "neutral" rating for the company in a research report on Friday, April 11th. Citigroup lowered their price objective on shares of Teladoc Health from $11.00 to $8.75 and set a "neutral" rating for the company in a research report on Friday, April 25th. Finally, Stifel Nicolaus lowered their price target on shares of Teladoc Health from $9.00 to $8.00 and set a "hold" rating for the company in a research report on Thursday, May 1st. Twelve investment analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company's stock. According to MarketBeat, Teladoc Health has a consensus rating of "Hold" and an average target price of $9.71.

Insider Buying and Selling

In related news, insider Adam C. Vandervoort sold 11,011 shares of the business's stock in a transaction on Thursday, March 20th. The shares were sold at an average price of $8.42, for a total transaction of $92,712.62. Following the transaction, the insider now directly owns 64,308 shares in the company, valued at approximately $541,473.36. The trade was a 14.62% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 0.58% of the stock is owned by corporate insiders.

Teladoc Health Stock Up 3.8%

Shares of NYSE TDOC traded up $0.27 during midday trading on Friday, reaching $7.52. The company's stock had a trading volume of 4,601,008 shares, compared to its average volume of 6,240,868. The company has a current ratio of 1.73, a quick ratio of 1.69 and a debt-to-equity ratio of 0.66. Teladoc Health, Inc. has a fifty-two week low of $6.35 and a fifty-two week high of $15.21. The stock has a market capitalization of $1.32 billion, a price-to-earnings ratio of -1.30 and a beta of 1.82. The stock has a 50 day simple moving average of $7.61 and a 200-day simple moving average of $9.37.

Teladoc Health (NYSE:TDOC - Get Free Report) last posted its quarterly earnings data on Wednesday, February 26th. The health services provider reported ($0.28) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.21) by ($0.07). Teladoc Health had a negative net margin of 37.91% and a negative return on equity of 10.06%. The business had revenue of $640.49 million during the quarter, compared to analyst estimates of $639.44 million. Equities research analysts predict that Teladoc Health, Inc. will post -1.16 earnings per share for the current year.

Teladoc Health Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.